Santiago Madero

170 Villarroel St, 12-0
Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: March 25, 2026

The PADRIS-PRESTO cohort: A comprehensive population-based study on mental health in Catalonia.

The PADRIS-PRESTO cohort: A comprehensive population-based study on mental health in Catalonia.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: September 19, 2025

Current perspectives on psychedelic treatments in Europe.

Current perspectives on psychedelic treatments in Europe.

Journal: The Lancet regional health. Europe

Published: August 04, 2025

Psychedelic interventions for major depressive disorder in the elderly: Exploring novel therapies, promise and potential.

Psychedelic interventions for major depressive disorder in the elderly: Exploring novel therapies, promise and potential.

Journal: Dialogues in clinical neuroscience

Published: May 06, 2025

Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort.

Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: January 16, 2025

Diagnostic pathways and mortality across psychotic disorders: Evidence from Catalonia integrated health records.

Diagnostic pathways and mortality across psychotic disorders: Evidence from Catalonia integrated health records.

Journal: Spanish journal of psychiatry and mental health

Published: December 05, 2024

Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study.

Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study.

Journal: BJPsych open

Published: August 01, 2024

Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder.

Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder.

Journal: Pharmacopsychiatry

Published: April 15, 2024

Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis.

Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis.

Journal: Journal of affective disorders

Published: April 02, 2024

Atlas of Gray Matter Volume Differences Across Psychiatric Conditions: A Systematic Review With a Novel Meta-Analysis That Considers Co-Occurring Disorders.

Atlas of Gray Matter Volume Differences Across Psychiatric Conditions: A Systematic Review With a Novel Meta-Analysis That Considers Co-Occurring Disorders.

Journal: Biological psychiatry

Published: February 06, 2024

Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.

Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 09, 2023

Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia.

Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia.

Journal: Schizophrenia research

Published: March 15, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026